Dara-SVD vs. Dara-RVD

A Randomized Phase 2 Study of Daratumumab-Selinexor-Velcade-Dexamethasone (Dara-SVD) for High-Risk Newly Diagnosed Multiple Myeloma

Near Add Your Location

Smilow Cancer Hospital at Yale New Haven
New Haven, CT
  • Accepting patients
  • Show Principal Investigator
UCI Health (Laguna Hills)
Laguna Hills, CA
  • Accepting patients
Chao Family Comprehensive Cancer Center
University of California, Irvine
Orange, CA
  • Accepting patients
Smilow Cancer Hospital
The Harold Leever Regional Cancer Center
Waterbury, CT
  • Accepting patients
Smilow Cancer Hospital
The Center for Cancer Care at Griffin Hospital
Derby, CT
  • Accepting patients
Smilow Cancer Hospital
Fairfield, CT
  • Accepting patients
Smilow Cancer Hospital
Saint Francis Hospital
Glastonbury, CT
  • Accepting patients
Smilow Cancer Hospital
Greenwich, CT
  • Accepting patients
Smilow Cancer Hospital
Shoreline Medical Center
Guilford, CT
  • Accepting patients
North Haven Medical Center
Yale-New Haven Hospital
North Haven, CT
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.